Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 15, 1992BloodOpen Access

Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial

View Full Paper
Ask AI
Bookmark
Share

Authors

PMPM MannucciFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoPTPM TenconiFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoGCGiancarlo CastamanAzienda Ospedaliero-Universitaria Careggi

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mannucci et al. (1992) studied this question.

synapsesocial.com/papers/6a6f9791e5469ee92be07ee3https://doi.org/10.1182/blood.v79.12.3130.3130
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities1976 · 94 citations
  2. 2Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy1981 · 3 citations
  3. 3Treatment of Von Willebrand Disease2001 · 35 citations
  4. 4Platelet factor VIII-related antigen: studies in vivo after transfusion in patients with von Willebrand disease1978 · 25 citations
  5. 5Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease1989 · 1 citations